RPB-supported researchers at Washington University School of Medicine in St. Louis have published a new study suggesting that aging immune cells increase the risk for age-related macular degeneration (AMD), a major cause of blindness in the United States.
The researchers found that as immune cells called macrophages age, they are more likely to contribute to the inflammation and abnormal blood vessel growth that damage vision in AMD. According to one of the lead researchers on the study, which was published in the scientific journal JCI Insight, the findings could impact future treatment options.
“Drug treatments for macular degeneration aren’t effective for some patients, who either have a minimal response or no response at all, and many patients continue to experience vision loss over the long term, even if they have a good initial response to treatment,” said senior investigator Rajendra S. Apte, MD, PhD, the Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences. “But by understanding what happens with the immune cells in the eye, it may be possible to develop therapies to help patients who can’t be helped with existing drugs.”
April 18, 2018
The awards offered cover a wide variety of topics in vision science, including glaucoma, age-related macular degeneration, retinal diseases, and many more.
Leaders of organizations that fund vision research convene in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
Dr. Alex Huang of the University of California San Diego School of Medicine will study glaucoma filtration surgeries with the aim of improving surgical success for lowering eye pressure and providing neuroprotection.
The new way to measure ocular aging opens treatment avenues for numerous eye diseases.
The American Academy of Ophthalmology (AAO) and Research to Prevent Blindness (RPB) today announced the 2023 recipients of the RPB/AAO Award for IRIS Registry Research.
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
General Info | Grants | News & Resources |